B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sapanisertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sapanisertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gedatolisib
6 shared targets
voxtalisib
5 shared targets
idelalisib
5 shared targets
pilaralisib
5 shared targets
eganelisib
5 shared targets
vistusertib
6 shared targets
zstk
5 shared targets
duvelisib
4 shared targets
bimiralisib
6 shared targets
copanlisib
5 shared targets
Loading evidence profile...

This evidence profile for Sapanisertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.